Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Lett ; 498: 42-53, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33188841

ABSTRACT

Pancreatic ductal adenocarcinoma (PDAC) shows poor prognosis and high malignancy due to the presence of cancer-initiating cells (CICs) and characteristics of the tumor microenvironment (TME). Organoids are useful for studying PDAC, and establishing organoids is dependent on stem cell growth factors, including Wnt signaling. Herein, using a conventional organoid culture system, we demonstrated that CD44(+)CD24(+) and CD44(+)CD24(+)EpCAM(+) CICs were enriched >65% in a PDAC patient-derived organoid. CICs expressing CD44 formed lumen structures by gathering into circles. Additionally, organoid-derived CD44(-) cancer cells were capable of organoid re-formation and could be re-programed as CD44-expressing CICs in the organoid culture system. To mimic a TME absent artificial stem cell growth factors, a PDAC organoid with vascular niche was established. CICs in the PDAC tumor organoid were maintained by paracrine effects and direct interactions with endothelial cells. Interestingly, CD44(+) cells in PDAC tumor tissue were detected primarily in the vascular niche. Inhibiting both Wnt and Notch signaling in endothelial cells suppressed organoid formation and the maintenance of CD24(+)CD44(+) CICs. Collectively, our results suggest that PDAC patient-derived organoids maintain CICs by interacting with endothelial cells via Wnt and Notch pathways.


Subject(s)
Endothelial Cells/pathology , Human Umbilical Vein Endothelial Cells/pathology , Organoids/pathology , Pancreatic Neoplasms/pathology , CD24 Antigen/metabolism , Carcinoma, Pancreatic Ductal/metabolism , Carcinoma, Pancreatic Ductal/pathology , Cell Line , Endothelial Cells/metabolism , Epithelial Cell Adhesion Molecule/metabolism , HEK293 Cells , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Hyaluronan Receptors/metabolism , Organoids/metabolism , Pancreatic Ducts/metabolism , Pancreatic Ducts/pathology , Pancreatic Neoplasms/metabolism , Receptors, Notch/metabolism , Signal Transduction/physiology , Stem Cells/metabolism , Stem Cells/pathology , Tumor Microenvironment/physiology , Wnt Signaling Pathway/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...